Weight-Loss Drugs Repurposed for Addiction: GLP-1 Trials Target Alcohol, Opioids, and Cocaine
More than 15 clinical trials are testing whether semaglutide and other GLP-1 receptor agonists can reduce cravings by altering dopamine pathways in the brain's reward system.
April 7, 20268 min read